S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
The Next Big Crisis Is Here (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
The Next Big Crisis Is Here (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
The Next Big Crisis Is Here (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
The Next Big Crisis Is Here (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
The Next Big Crisis Is Here (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
The Next Big Crisis Is Here (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
The Next Big Crisis Is Here (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
The Next Big Crisis Is Here (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
The Next Big Crisis Is Here (Ad)
Mergers and Acquisitions in 2023 Off To A Strong Start
Chevron Delights Shareholders with $75 Billion in Share Buybacks
NASDAQ:ATEC

Alphatec - ATEC Stock Forecast, Price & News

$12.76
-0.07 (-0.55%)
(As of 01/26/2023 12:00 AM ET)
Add
Compare
Today's Range
$12.71
$13.21
50-Day Range
$9.45
$13.49
52-Week Range
$5.73
$13.75
Volume
356,472 shs
Average Volume
1.03 million shs
Market Capitalization
$1.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.64

Alphatec MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
22.6% Upside
$15.64 Price Target
Short Interest
Bearish
11.41% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
0.13mentions of Alphatec in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$3.09 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.44) to ($1.05) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.79 out of 5 stars

Medical Sector

780th out of 1,048 stocks

Surgical & Medical Instruments Industry

78th out of 104 stocks


ATEC stock logo

About Alphatec (NASDAQ:ATEC) Stock

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.

Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Alphatec (NASDAQ:ATEC) Trading Down 3.7% Following Insider Selling
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
ATEC Advances Lateral Sophistication
See More Headlines
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Company Calendar

Last Earnings
11/03/2022
Today
1/27/2023
Next Earnings (Estimated)
3/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ATEC
CUSIP
02081G10
Employees
561
Year Founded
1990

Price Target and Rating

Average Stock Price Forecast
$15.64
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$9.50
Forecasted Upside/Downside
+22.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-144,330,000.00
Pretax Margin
-49.20%

Debt

Sales & Book Value

Annual Sales
$243.21 million
Book Value
$0.80 per share

Miscellaneous

Free Float
69,412,000
Market Cap
$1.34 billion
Optionable
Not Optionable
Beta
1.32

Social Links


Key Executives

  • Mr. Patrick S. MilesMr. Patrick S. Miles (Age 57)
    Exec. Chairman, CEO & Pres
    Comp: $1.57M
  • Mr. J. Todd Koning (Age 50)
    Exec. VP & CFO
    Comp: $772.43k
  • Mr. Craig E. HunsakerMr. Craig E. Hunsaker (Age 59)
    Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel
    Comp: $850.97k
  • Mr. Brian R. Snider (Age 45)
    Exec. VP of Marketing
  • Mr. David P. SponselMr. David P. Sponsel (Age 44)
    Exec. VP of Sales
  • Mr. Jonathan Allen (Age 63)
    Exec. VP of Commercial Operations
  • Mr. Scott  LishMr. Scott Lish (Age 41)
    Sr. VP of R&D
  • Dr. Luiz Pimenta
    Chief Medical Officer
  • Ms. Kelli Mari Howell (Age 49)
    Exec. VP of Clinical Strategies
  • Mr. Eric Dasso (Age 49)
    Exec. VP of Adjunctive Technologies













ATEC Stock - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings
or view top-rated stocks.

What is Alphatec's stock price forecast for 2023?

6 brokers have issued 1 year price objectives for Alphatec's shares. Their ATEC share price forecasts range from $9.50 to $20.00. On average, they expect the company's stock price to reach $15.64 in the next year. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for ATEC
or view top-rated stocks among Wall Street analysts.

How have ATEC shares performed in 2023?

Alphatec's stock was trading at $12.35 on January 1st, 2023. Since then, ATEC stock has increased by 3.3% and is now trading at $12.76.
View the best growth stocks for 2023 here
.

Are investors shorting Alphatec?

Alphatec saw a increase in short interest in January. As of January 15th, there was short interest totaling 7,330,000 shares, an increase of 12.1% from the December 31st total of 6,540,000 shares. Based on an average trading volume of 863,900 shares, the days-to-cover ratio is presently 8.5 days. Approximately 11.4% of the company's shares are short sold.
View Alphatec's Short Interest
.

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our ATEC earnings forecast
.

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) issued its quarterly earnings data on Thursday, November, 3rd. The medical technology company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.32) by $0.03. The medical technology company had revenue of $89.84 million for the quarter, compared to the consensus estimate of $87.07 million. Alphatec had a negative trailing twelve-month return on equity of 575.45% and a negative net margin of 49.34%.

What guidance has Alphatec issued on next quarter's earnings?

Alphatec issued an update on its FY 2022 earnings guidance on Tuesday, January, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $350.10 million-$351.10 million, compared to the consensus revenue estimate of $340.28 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?
What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

Who are Alphatec's major shareholders?

Alphatec's stock is owned by many different retail and institutional investors. Top institutional shareholders include Waypoint Capital Advisors LLC (0.25%), Assenagon Asset Management S.A. (0.20%), Perkins Capital Management Inc. (0.17%), Cyndeo Wealth Partners LLC (0.04%) and Elk River Wealth Management LLC (0.01%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jeffrey G Black, Jennifer N Pritzker, Jennifer N Pritzker, Mortimer Berkowitz III, Patrick Miles, Paul Segal and Scott Lish.
View institutional ownership trends
.

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $12.76.

How much money does Alphatec make?

Alphatec (NASDAQ:ATEC) has a market capitalization of $1.34 billion and generates $243.21 million in revenue each year. The medical technology company earns $-144,330,000.00 in net income (profit) each year or ($1.54) on an earnings per share basis.

How many employees does Alphatec have?

The company employs 561 workers across the globe.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The official website for the company is www.atecspine.com. The medical technology company can be reached via phone at (760) 431-9286, via email at ir@alphatecspine.com, or via fax at 800-922-1356.

This page (NASDAQ:ATEC) was last updated on 1/27/2023 by MarketBeat.com Staff